All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
AAHP Shares FDA’s Commitment to Protecting Public Health
December 19, 2017 In response to the U.S. Food and Drug Administration's (FDA) draft guidance on homeopathic drug products released on Monday, December 18, 2017,...
Arnica montana: A Clinical Snapshot
By Todd Hoover, MD December 11, 2017 Arnica montana has been used for centuries as a phytomedicine for its analgesic and anti-inflammatory properties. Commonly known...
2017 Year in Review
2017 was a busy year for AAHP. With a new administration in the White House and key legislative issues heating up, the association had a...
Steps Toward Building Grassroots Support
December 6, 2017 Since the FDA hearing and the FTC workshop in 2015, the homeopathic industry has received more attention than usual from regulators. While...
Recall Preparedness
By Mark Land, AAHP president November 20, 2017 Risks associated with the therapeutic use of healthcare products are real. Manufacturers and the U.S. Food and...
Upcoming Webinar to Highlight Homeopathic Drug Stability
MILWAUKIE, Ore. (Nov. 14, 2017) – The American Association of Homeopathic Pharmacists (AAHP) will host a two-part webinar series on stability studies for homeopathic drug...
Annual Certification of Drug Product Listings
By Leonard Krause, FDA Connect November 1, 2017 It is that time of year again. Days are getting shorter and colder, and AAHP members who...
